Journal of Korean Neurosurgical Society

Reduced volume intensity-modulated radiotherapy with simultaneous integrated boost for patients with high-grade glioma: A retrospective observational study

Hye Jin Kang, Myungsoo Kim, Yoo-Kang Kwak, Jinsol Shin, So Jung Lee

A Systematic Review and Meta-Analysis on the Number of Adjuvant Temozolomide Cycles in Newly Diagnosed Glioblastoma

Fahimeh Attarian, Farzad Taghizadeh-Hesary, Azar Fanipakdel, Seyed Alireza Javadinia, Pejman Porouhan, Babak PeyroShabany, Danial Fazilat-Panah

Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)

Kihwan Hwang, Tae Min Kim, Chul-Kee Park, Jong Hee Chang, Tae-Young Jung, Jin Hee Kim, Do-Hyun Nam, Se-Hyuk Kim, Heon Yoo, Yong-Kil Hong, Eun-Young Kim, Dong-Eun Lee, Jungnam Joo, Yu Jung Kim, Gheeyoung Choe, Byung Se Choi, Seok-Gu Kang, Jeong Hoon Kim, C

Cancer Research and Treatment.2020; 52(2): 505. CrossRef

C. Leitzen, T. Wilhelm-Buchstab, L. C. Schmeel, S. Garbe, S. Greschus, T. Müdder, S. Oberste-Beulmann, B. Simon, H. H. Schild, H. Schüller

Strahlentherapie und Onkologie.2016; 192(7): 481. CrossRef

Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution

Jin-Deok Joo, Hansol Kim, Young-Hoon Kim, Jung Ho Han, Chae-Yong Kim

Journal of Korean Medical Science.2015; 30(11): 1597. CrossRef

Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients

Jin-Deok Joo, Jong Hee Chang, Jeong Hoon Kim, Yong-Kil Hong, Young-Hoon Kim, Chae-Yong Kim

Journal of Korean Neurosurgical Society.2012; 52(2): 92. CrossRef

Clinical and biological significance of Nemo-like kinase expression in glioma

Gang Cui, Zhen Li, Bai Shao, Li Zhao, Yanfeng Zhou, Ting Lu, Junxiang Wang, Xioayong Shi, Jinjin Wang, Gang Zuo, Weiwei Zhu, Aiguo Shen

Journal of Clinical Neuroscience.2011; 18(2): 271. CrossRef

Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review

Wook-Ha Kim, Sang Hoon Yoon, Chae-Yong Kim, Ki-jeong Kim, Min Mi Lee, Gheeyoung Choe, In-Ah Kim, Jee Hyun Kim, Yu Jung Kim, Hyun-Jib Kim

Journal of Neuro-Oncology.2011; 101(2): 247. CrossRef

Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study

Young-Hoon Kim, Chul-Kee Park, Won Ho Cho, In Ah Kim, Seyoung Moon, Gheeyoung Choe, Sung-Hye Park, Il Han Kim, Dong Gyu Kim, Hee-Won Jung, Min Mi Lee, So Hyun Bae, Seung Heon Cha, Chae-Yong Kim

Journal of Neuro-Oncology.2011; 103(3): 503. CrossRef

Prognoseeinschätzung durch MR-Verlaufskontrollen während der Strahlentherapie bei Glioblastom-Patienten

Christina Leitzen, Hans H. Schild, Birgitta Bungart, Ulrich Herrlinger, Christiana Lütter, Thomas Müdder, Timo Wilhelm-Buchstab, Heinrich Schüller

Strahlentherapie und Onkologie.2010; 186(12): 681. CrossRef

Clinical and biological significance of forkhead class box O 3a expression in glioma: mediation of glioma malignancy by transcriptional regulation of p27kip1

Jinlong Shi, Li Zhang, Aiguo Shen, Jianguo Zhang, Yuchan Wang, Yueming Zhao, Lin Zou, Qing Ke, Fei He, Ping Wang, Chun Cheng, Gongshen Shi

Journal of Neuro-Oncology.2010; 98(1): 57. CrossRef

A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study

Chae-Yong Kim, Seung-Ki Kim, Ji Hoon Phi, Min Mi Lee, In Ah Kim, Il Han Kim, Kyu-Chang Wang, Hye-Lim Jung, Mee Jeong Lee, Byung-Kyu Cho

Journal of Neuro-Oncology.2010; 100(2): 193. CrossRef

Combined Radio- and Chemotherapy of Brain Tumours in Adult Patients